COMPARISON OF PREOPERATIVE TOPICAL NEPAFENAC (0.1%), FLURBIPROFEN (0.03%) AND KETOROLAC (0.4%) EYE DROPS IN MAINTAINING MYDRIASIS DURING PHACOEMULSIFICATION- A RANDOMISED, DOUBLE-BLIND STUDY
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2017, Vol 6, Issue 40
Abstract
BACKGROUND Phacoemulsification with IOL implantation is the current surgical treatment of choice for cataract extraction. Intraoperative manipulation during surgery triggers inflammatory cascade resulting in miosis, pain, inflammation or cystoid macular oedema. Adequate pupillary dilatation and its maintenance is required for proper anterior capsule incision and nucleus delivery and IOL implantation failing which may lead to complications. Aim- This study compares the effectiveness of prophylactic administration of topical flurbiprofen 0.03%, nepafenac 0.1% and ketorolac 0.4% in maintaining mydriasis during phacoemulsification with IOL implantation in the capsular bag. MATERIALS AND METHODS It is a prospective, randomised, double blind study involving 120 eyes undergoing phacoemulsification which were randomly and equally divided into four groups receiving topical nepafenac 0.1% (Group 1), flurbiprofen 0.03% (Group 2), ketorolac 0.4% (Group 3), placebo CMC 0.5% (Group 4) prior to the surgery. Pupil diameters were recorded at different stages of surgery and the mean value was compared. All the data was analysed with the software SPSS 20.0. Chi square test and ANOVA was used for comparison amongst the four groups. RESULTS Total 120 eyes were included, 50 females and 70 males of mean age 59.458 ± 8.74 years. The pupil diameter at the baseline was comparable in all four groups. Significant difference was seen in the pupil diameter in all the groups; however, nepafenac group had the least decrease in the pupil diameter at the end of surgery (P = 0.009). CONCLUSION Topical nepafenac has shown to be a potent inhibitor of miosis during phacoemulsification and also maintained the mydriasis throughout the procedure as compared to topical flurbiprofen, ketorolac and placebo.
Authors and Affiliations
Supriya Mushrif, Kaynat Patel
Keywords
Related Articles
- EP ID EP213292
- DOI 10.14260/Jemds/2017/689
- Views 82
- Downloads 0
EVALUATION OF MEAN PLATELET VOLUME AS A PROGNOSTIC MARKER IN TYPE II DIABETES MELLITUS
[b]BACKGROUND:[/b] Diabetes mellitus (DM) is both metabolic disorder and a major worldwide health problem because of its high prevalence and mortality. The prevalence of cardiovascular complication of type II D...
BILATERAL OPEN TYPE IIIB INJURIES- “FLOATING FOREARM” WITH CONTRALATERAL DISTAL RADIUS PHYSEAL SEPARATION- A RARE CASE REPORT
PRESENTATION OF CASE A ten-year-old boy presented to our emergency department with multiple injuries to both upper limbs following fall to the ground on outstretched hands from a mango tree of around 20 feet high. He had...
A STUDY OF THYROID DYSFUNCTION IN HIV SEROPOSITIVE PATIENTS
BACKGROUND There has been significant increase in the prevalence of HIV and with use of HAART there has been significant increase in the survival of HIV infected individuals, leading to increased detection of comorbid co...
TIMELINESS OF CHILDHOOD VACCINE UPTAKE AMONG CHILDREN ATTENDING IMMUNOPROPHYLAXIS CLINIC IN CENTRAL INDIA
BACKGROUND Child survival is dependent on many survival factors including immunisation. Even though, vaccines are provided free of cost at all government healthcare centers, the immunisation coverage in India is very low...
A STUDY OF THE UROLOGICAL COMPLICATIONS FOLLOWING SEX REASSIGNMENT SURGERY
BACKGROUND Sex reassignment surgery is the GOLD standard in the management of gender dysphoria. As the issue of gender dysphoria is on the rise, new management strategies need to be evolved in the way of multidisciplinar...